120 related articles for article (PubMed ID: 34794218)
1. [Expression of hepatocyte nuclear factor 4γ in gastric carcinoma and its role in cell proliferation and stemness].
Jia YX; Tang H; Chang ZW; Fan HJ; Guan XY; Qin YR
Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1164-1169. PubMed ID: 34794218
[No Abstract] [Full Text] [Related]
2. miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach.
Sousa JF; Nam KT; Petersen CP; Lee HJ; Yang HK; Kim WH; Goldenring JR
Gut; 2016 Jun; 65(6):914-24. PubMed ID: 25800782
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma.
Cui M; Yu W; Dong J; Chen J; Zhang X; Liu Y
Med Oncol; 2010 Sep; 27(3):632-9. PubMed ID: 19554484
[TBL] [Abstract][Full Text] [Related]
4. [Expression of thioredoxin reductase 1 (TrxR1) in gastric cancer and its effect on the growth of gastric cancer cells].
Fan YS; Qiu ZS; Zhao YP
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jul; 36(4):324-329. PubMed ID: 33167092
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer.
Chu XD; Lin ZB; Huang T; Ding H; Zhang YR; Zhao Z; Huangfu SC; Qiu SH; Guo YG; Chu XL; Pan JH; Pan YL
BMC Cancer; 2022 Mar; 22(1):250. PubMed ID: 35255858
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.
Wang DD; Chen YB; Pan K; Wang W; Chen SP; Chen JG; Zhao JJ; Lv L; Pan QZ; Li YQ; Wang QJ; Huang LX; Ke ML; He J; Xia JC
PLoS One; 2012; 7(7):e40364. PubMed ID: 22808142
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
9. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
[TBL] [Abstract][Full Text] [Related]
10. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
11. Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
Sun Z; Gao X; Zabkiewicz C; Ruge F; Xie M; Cai S; Sun PH; Griffiths P; Pugh MR; Ji J; Jiang WG; Ye L
Int J Oncol; 2020 Sep; 57(3):813-824. PubMed ID: 32705152
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
Gao XY; Li L; Wang XH; Wen XZ; Ji K; Ye L; Cai J; Jiang WG; Ji JF
Oncol Rep; 2015 Oct; 34(4):1977-87. PubMed ID: 26239167
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling.
Li H; Wang Y
Med Sci Monit; 2019 Jan; 25():656-665. PubMed ID: 30670679
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognosis of MYOZ2 in gastric cancer.
Li YF; Zhu GY; Ma Y; Qu HY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5920-5927. PubMed ID: 30280773
[TBL] [Abstract][Full Text] [Related]
15. [Association of Serine/Threonine Phosphoprotein Phosphatase 4C Expression With Prognosis of Gastric Cancer].
Geng ZJ; Huang J; Li QQ; Zhou ZX; Li J; Zhang XF; Wang L; Wang YY; Song X; Zuo LG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):721-729. PubMed ID: 37927012
[TBL] [Abstract][Full Text] [Related]
16. TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma.
Yang Y; Zuo S; Li W; Di M; Liu J; Chai J; Wang J; Yuan Y; Li M; Jia Q
Pathol Res Pract; 2023 Aug; 248():154710. PubMed ID: 37494805
[TBL] [Abstract][Full Text] [Related]
17. MiR-144-3p inhibits gastric cancer progression and stemness via directly targeting GLI2 involved in hedgehog pathway.
Lu Y; Zhang B; Wang B; Wu D; Wang C; Gao Y; Liang W; Xi H; Wang X; Chen L
J Transl Med; 2021 Oct; 19(1):432. PubMed ID: 34657624
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
19. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
Xi Z; Si J; Nan J
Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
